section name header

Y-Site Injection Compatibility (1:1 Mixture)

Tobramycin sulfate

(Conc: 6 mg/mL)

C

Ceftazidime

(Mfr: GSK)(Conc: 120 mg/mLq)

Remarks:

Physically compatible with less than 10% ceftazidime loss. Tobramycin not tested

Ref:

2513